Barbara L. Weber

Active 1980–2022

77
Papers
44,533
Citations
73
h-index
77
i10-index

Citations

Citations per year for Barbara L. Weber1948: 1 citations1981: 1 citations1982: 4 citations1983: 1 citations1985: 1 citations1986: 1 citations1987: 2 citations1988: 2 citations1989: 1 citations1990: 2 citations1992: 4 citations1993: 4 citations1994: 4 citations1995: 41 citations1996: 91 citations1997: 117 citations1998: 132 citations1999: 175 citations2000: 206 citations2001: 160 citations2002: 226 citations2003: 346 citations2004: 413 citations2005: 442 citations2006: 454 citations2007: 435 citations2008: 479 citations2009: 486 citations2010: 529 citations2011: 554 citations2012: 631 citations2013: 655 citations2014: 666 citations2015: 592 citations2016: 538 citations2017: 513 citations2018: 477 citations2019: 1,202 citations2020: 1,200 citations2021: 1,133 citations2022: 761 citations2023: 520 citations2024: 816 citations2025: 348 citations2026: 30 citations1949–1980: no citations, so these years are not shown1984: no citations, so this year is not shown1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,974 citing papers, 33.1% of this breakdownChina: 1,827 citing papers, 8.7% of this breakdownUnited Kingdom: 1,532 citing papers, 7.3% of this breakdownGermany: 1,081 citing papers, 5.1% of this breakdownItaly: 802 citing papers, 3.8% of this breakdownCanada: 735 citing papers, 3.5% of this breakdownFrance: 732 citing papers, 3.5% of this breakdownAustralia: 635 citing papers, 3% of this breakdownJapan: 597 citing papers, 2.8% of this breakdownNetherlands: 579 citing papers, 2.8% of this breakdownSpain: 513 citing papers, 2.4% of this breakdownSwitzerland: 465 citing papers, 2.2% of this breakdown
0%33.1%Other 21.8%

Fields

  • Biochemistry, Genetics and Molecular Biology58.1%
  • Medicine31.1%
  • Computer Science4.7%
  • Immunology and Microbiology1.9%
  • Neuroscience0.7%
  • Agricultural and Biological Sciences0.6%
  • Other2.9%

Topics

  • Melanoma and MAPK Pathways5.2%
  • Cancer Genomics and Diagnostics4%
  • BRCA gene mutations in cancer3.7%
  • Computational Drug Discovery Methods3.2%
  • Bioinformatics and Genomic Networks2.6%
  • DNA Repair Mechanisms2.4%
  • Other78.9%

Coauthors

All papers

Open in search
  1. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway - Nature 2012 cited by 8,599

  2. Mutations of the BRAF gene in human cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Darren Hargrave, Katherine Pritchard-Jones, Norman J. Maitland, Georgia Chenevix‐Trench, Gregory J. Riggins, Darell D. Bigner, Giuseppe Palmieri, Antonio Cossu, Adrienne M. Flanagan, Andrew G. Nicholson, Judy Ho, Suet Yi Leung, Siu Tsan Yuen, Barbara L. Weber, Hilliard F. Seigler, Timothy L. Darrow, Hugh Paterson, Richard Marais, Christopher J. Marshall, Richard Wooster, Michael R. Stratton, P. Andrew Futreal - Nature 2002 cited by 10,737

  3. Synthetic lethality as an engine for cancer drug target discovery

    Authors: , , , - Nature Reviews Drug Discovery 2019 cited by 469

  4. Patterns of somatic mutation in human cancer genomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andy Menzies, Tatiana Mironenko, Janet Perry, Keiran Raine, David Richardson, Rebecca Shepherd, Alexandra Small, Calli Tofts, Jennifer Varian, Tony Webb, Sofie West, Sara Widaa, Andy Yates, Daniel P. Cahill, David N. Louis, Peter Goldstraw, Andrew G. Nicholson, Francis Brasseur, Leendert H. J. Looijenga, Barbara L. Weber, Yoke-Eng Chiew, Anna DeFazio, Mel Greaves, Anthony R. Green, Peter J. Campbell, Ewan Birney, Douglas F. Easton, Georgia Chenevix‐Trench, Min-Han Tan, Sok Kean Khoo, Bin Tean Teh, Siu Tsan Yuen, Suet Yi Leung, Richard Wooster, P. Andrew Futreal, Michael R. Stratton - Nature 2007 cited by 3,147

  5. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William R. Sellers, Robert Schlegel, Jennifer A. Wargo, William C. Hahn, Levi A. Garraway - Nature 2010 cited by 1,465

  6. Intragenic ERBB2 kinase mutations in tumours

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Petty, Keiran Raine, Lewis Ratford, Rebecca Shepherd, Alexandra Small, Yvonne Stephens, Calli Tofts, Jennifer Varian, Sofie West, Sara Widaa, Andrew Yates, Francis Brasseur, Colin S. Cooper, Adrienne M. Flanagan, Margaret A. Knowles, Suet Yi Leung, David N. Louis, Leendert H. J. Looijenga, Bruce Malkowicz, Marco A. Pierotti, Bin Tean Teh, Georgia Chenevix‐Trench, Barbara L. Weber, Siu Tsan Yuen, Grace Harris, Peter Goldstraw, Andrew G. Nicholson, P. Andrew Futreal, Richard Wooster, Michael R. Stratton - Nature 2004 cited by 792

  7. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victoria Murday, Catherine Phelan, Steven A. Narod, T. Peretz, Julian Peto, Julian Peto, Barbara L. Weber, Hong Xiang Zhang, Katherine L. Nathanson, David E. Goldgar, Csilla I. Szabo - Nature Genetics 2002 cited by 1,109

  8. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

    Authors: , , , , , , , , , , , - Pigment Cell Research 2006 cited by 567

  9. VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2022 cited by 65

  10. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Folusho Omodele, Odunayo Akinyele, Adewunmi Adeoye, Temidayo O. Ogundiran, Chinedum P. Babalola, Kenzie D. MacIsaac, Abiodun Popoola, Michael Morrissey, Lin Chen, Jiebiao Wang, Christopher O. Olopade, Adeyinka G. Falusi, Wendy Winckler, Kerstin Haase, Peter Van Loo, John Obafunwa, D Papoutsakis, Oladosu Ojengbede, Barbara L. Weber, Nasiru Ibrahim, Kevin P. White, Dezheng Huo, Olufunmilayo I. Olopade, Jordi Barretina - Nature Communications 2018 cited by 139

  11. BRAF and RAS mutations in human lung cancer and melanoma.

    Authors: , , , , , , , , , , , , , , , , , , , - 2002 cited by 1,027

  12. Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations

    Authors: , , , , , , , , , , , - New England Journal of Medicine 2002 cited by 1,462

  13. Somatic Mutations of the Protein Kinase Gene Family in Human Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard Lugg, Andrew Menzies, Janet Perry, Robert Petty, Keiran Raine, Rebecca Shepherd, Alexandra Small, Helen Solomon, Yvonne Stephens, Calli Tofts, Jennifer Varian, Anthony Webb, Sofie West, Sara Widaa, Andrew Yates, Francis Brasseur, Colin S. Cooper, Adrienne M. Flanagan, Anthony R. Green, Maggie Knowles, Suet Yi Leung, Leendert H. J. Looijenga, Bruce Malkowicz, Marco A. Pierotti, Bin Tean Teh, Siu Tsan Yuen, Sunil R. Lakhani, Douglas F. Easton, Barbara L. Weber, Peter Goldstraw, Andrew G. Nicholson, Richard Wooster, Michael R. Stratton, P. Andrew Futreal - Cancer Research 2005 cited by 466

  14. Type VI secretion modulates quorum sensing and stress response in Vibrio anguillarum

    Authors: , , , , - Environmental Microbiology 2009 cited by 150

  15. Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway - Nature 2012 cited by 112

  16. Optimizing the Therapeutic Window of Targeted Drugs in Oncology: Potency‐Guided First‐in‐Human Studies

    Authors: , , , - Clinical and Translational Science 2020 cited by 38

  17. FGFR1 Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2006 cited by 269

  18. Aging and Chronic Sun Exposure Cause Distinct Epigenetic Changes in Human Skin

    Authors: , , , , , , , , - PLoS Genetics 2010 cited by 262

  19. Dietary probiotic supplementation modulated gut microbiota and improved growth of juvenile rainbow trout (Oncorhynchus mykiss)

    Authors: , , , , , - Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology 2013 cited by 105

  20. Network modeling links breast cancer susceptibility and centrosome dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Livingston, Stephen B. Gruber, Jeffrey D. Parvin, Marc Vidal - Nature Genetics 2007 cited by 634

  21. BRCA1 physically associates with p53 and stimulates its transcriptional activity

    Authors: , , , , , , , - Oncogene 1998 cited by 497

  22. Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2006 cited by 337

  23. Role for ATM in DNA damage-induced phosphorylation of BRCA1.

    Authors: , , , , , , - 2000 cited by 252

  24. Coronamycins, peptide antibiotics produced by a verticillate Streptomyces sp. (MSU-2110) endophytic on Monstera sp.

    Authors: , , , , , , , , , , , , - Microbiology 2004 cited by 248